γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer.

Sci Adv · 2023 · PMC10156127 · PMID 37134157

Europe PMC DOI

hedged sentence

0.0567

closest p · 1.1× alpha

0.0567

boldest claim

The sentences

did not reach statistical significanceP = 0.0567so close (0.05 < p ≤ 0.1)

A similar trend was observed in the γδ CAR-T group but did not reach statistical significance ( P = 0.0567).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.